Live feed
Filing
SC 13D
SC 13D0001654954-17-003113·Echo Therapeutics, Inc.
Schedule 13D ownership disclosure
Echo Therapeutics, Inc.
Security class unavailable · CUSIP: 27876L107
Event date: 2017-03-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-17-003113
- Form type
- SC 13D
- Filer
- Echo Therapeutics, Inc.
- CIK
- CIK 1031927
- Filed
- Apr 06, 2017
- Reporting period
- Mar 21, 2017
- Description
- Schedule 13D beneficial ownership